CCGroup Seeks Injunction Against OptumInsight’s Impact Intelligence Software

May 13, 2015
Healthcare-Compliance

CCGroup Seeks Injunction Against OptumInsight’s Impact Intelligence Software

SAN MATEO, Calif.–(BUSINESS WIRE)–A California federal jury determined that UnitedHealth Group’s subsidiary OptumInsight infringed Cave Consulting Group’s patent for measuring physician efficiency. The federal jury determined that OptumInsight infringed the U.S. Patent No. 7,739,126 (“‘126 patent”) by operating and licensing its Impact Intelligence software, a competing solution for developing physician efficiency scores.

“The jury found that OptumInsight’s Impact Intelligence software infringed because it uses, among other things, a pre-defined set of medical conditions to evaluate each specialty type,” stated Dr. Douglas G. Cave, President of Cave Consulting Group. The pre-defined set of medical conditions is a key component of the methodology protected by Cave Consulting Group’s ‘126 Patent.

Read full article here.

Leave a Comment

(required)

(required)

(required)